Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a ‘disorderly’ no-deal Brexit.
“It is vital that Government makes minimising disruption to the medicines supply the highest priority as it prepares for a potential hard or disorderly Brexit and ensures cooperation over medicines regulation in this event,” the company said.
Original Article: Novartis warns of huge impact of no-deal Brexit